Avantor, Inc. (NYSE:AVTR) Stock Position Lowered by Artemis Investment Management LLP

Artemis Investment Management LLP trimmed its holdings in Avantor, Inc. (NYSE:AVTR) by 49.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 4,040,069 shares of the company’s stock after selling 4,028,411 shares during the period. Avantor makes up about 1.6% of Artemis Investment Management LLP’s holdings, making the stock its 8th largest holding. Artemis Investment Management LLP owned approximately 0.59% of Avantor worth $104,517,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in AVTR. Versant Capital Management Inc raised its holdings in shares of Avantor by 2,003.6% in the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after buying an additional 1,102 shares during the period. Blue Trust Inc. lifted its position in shares of Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after purchasing an additional 1,391 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after purchasing an additional 1,285 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH acquired a new position in shares of Avantor in the first quarter valued at approximately $93,000. Finally, ORG Partners LLC increased its stake in Avantor by 5,773.0% during the 2nd quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after buying an additional 5,773 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Activity

In related news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.50% of the company’s stock.

Avantor Price Performance

Shares of NYSE AVTR opened at $24.82 on Wednesday. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The stock has a market cap of $16.86 billion, a P/E ratio of 63.64, a P/E/G ratio of 2.71 and a beta of 1.33. The stock has a 50 day moving average of $25.81 and a two-hundred day moving average of $24.37. Avantor, Inc. has a twelve month low of $16.63 and a twelve month high of $28.00.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. The company had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.70 billion. Avantor had a net margin of 5.28% and a return on equity of 12.40%. On average, research analysts forecast that Avantor, Inc. will post 1.01 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Robert W. Baird boosted their price target on shares of Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a research note on Monday, July 29th. Citigroup cut Avantor from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $30.00 to $23.00 in a research note on Wednesday, July 10th. Stifel Nicolaus raised their target price on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, July 29th. TD Cowen increased their price objective on shares of Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Finally, Morgan Stanley lifted their price objective on shares of Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $28.00.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.